RealityCorp’s ClinTest Voice v4.0 Provides First-In-Class Testing and Validation Solution for Interactive Voice Response S

Create Test Scripts, Automate Test Execution, and Produce Objective Evidence from One Platform

WILMINGTON, Del.--(BUSINESS WIRE)-- RealityCorp is proud to announce the release of ClinTestTM Voice v4.0. ClinTest Voice, the market leading eClinical functional testing product utilized for the automated validation of Interactive Voice Response (IVR) systems, has been upgraded with best-in-class features and enhancements to accommodate the most diverse, complex, and dynamic IVR systems.

The upgraded release of ClinTestTM Voice (v4.0) aligns RealityCorp’s industry leading validation products into a unified suite, providing a cohesive framework between ClinTestTM Voice v4.0 and its sister product, ClinTestTM Web v4.0. Utilizing the ClinTestTM suite of cutting edge automated validation tools, Users will be able to dramatically shorten their Software Development Life Cycle on Web based or IVR system deliverables; allowing our User’s system(s) to be released into production faster, complete with automatically generated Objective Evidence that adheres to all applicable Good Clinical Practices and Good Documentation Practices. RealityCorp’s primary objective is to provide our Users next generation automation technology which saves both time and cost while not compromising on quality or process. All RealityCorp software was created by clinical industry professionals in order to expedite the eClinical SDLC while preserving the expectations and standards of any Regulatory Compliance group.

ClinTestTM Voice v4.0 provides automated validation of standard call flows utilizing voice-to-text capabilities to determine spoken prompt accuracy (up to 100%), as well as a full complement of XML file verification actions, File System verification actions, enhanced database interactions, and capabilities for entering text to speech inputs for IVR systems that support speech recognition. Gearing our products towards the future of industry technology, RealityCorp is excited to provide the eClinical space the flexibility to adopt new IVR technology safely through the utilization of ClinTestTM Voice v4.0 in the validation process. Acting as a technology bridge, ClinTestTM Voice v4.0 provides the ability to interact with all types of IVR systems by allowing the validation of features such as text-to-speech input and .wav playback capabilities. These groundbreaking achievements, coupled with RealityCorp’s proprietary Silence Detection Technology, allows Users to interact with every type of call flow, from simple DTMF entry to Voice Recognition based IVRS. ClinTestTM Voice v4.0 still allows Users to configure accuracy thresholds at the global or individual step level for pass, manual verification, and failure statuses; while providing a unique feature to automation - allowing Users to configure test scripts for expected failures.

“We are consistently striving for excellence and that is reflected in our latest release of ClinTest Voice v4.0,” remarked Carlton Schowe, President and CEO of RealityCorp. “The goal of this release is to make everyone’s life easier, without compromising quality, for those involved in the development, testing, and quality assurance of eClinical IVRS. Although ClinTest Voice provides the most complete objective evidence output reports in the market, the best feature of the product is that our Users will never have to pick up the phone to validate an IVR system again.”

RealityCorp, based in Wilmington, Delaware, was founded in 2000. RealityCorp focuses on eClinical automated testing products and services utilizing their proprietary automation framework, ClinTestTM. By adopting ClinTestTM as a business solution, our Clients not only benefit from the potential to accelerate the eClinical software development life cycle but also benefit from the knowledge of industry professional supporting their products. ClinTestTM provides a targeted, next-generation solution for functional testing, test result reporting, and objective evidence collection.

For any additional information please visit our web site at or contact the Marketing Department at [email protected] or 1-302-995-2770 ext. 111.


Carlton Schowe, 302-995-0200 x601
President and CEO
[email protected]

KEYWORDS:   United States  North America  Delaware

INDUSTRY KEYWORDS:   Technology  Data Management  Internet  Software  Health  Biotechnology  Clinical Trials  Research  Science




Driving Engagement in an Evolving Healthcare Ecosystem

Deep-dive into evolving consumer expectations in healthcare today and how leading providers are shaping their infrastructure to connect with patients through virtual care.

Suggested Articles

UPMC Health Plan is expanding its medication adherence program with Sempre Health to include diabetes medications.

Despite efforts to improve patient safety over the past 20 years, results have not been optimal. We raise vital questions and renewed areas of focus.

The Trump administration has enlisted CVS Health to pilot administering the therapy to patients in long-term care facilities and at home.